Press "esc" to clear
Go to Advanced Search

Showing results

110 of 435
PierPaoloPandolfi04231551edited.jpg

Article ID: 693192

BIDMC-Lead Team Develops New Approach to Study Non-Coding RNAs

Beth Israel Deaconess Medical Center

In a groundbreaking paper published today in the journal Cell, investigators at the Cancer Research Institute Beth Israel Deaconess Medical Center (BIDMC) have found dozens of important new genes, both coding and non-coding that impact sensitivity to chemotherapy. In doing so, the scientists developed a novel technique that marries CRISPR technology with big data mining to identify and assign function to non-coding RNAs

Released:
19-Apr-2018 3:55 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
TLibermannMBhasin111440.jpg
  • Embargo expired:
    4-Apr-2018 9:00 AM EDT

Article ID: 692174

Relaxation Response Therapy May Reduce Blood Pressure by Altering Expression of a Distinct Set of Genes

Beth Israel Deaconess Medical Center

A new study led by investigators at Beth Israel Deaconess Medical Center (BIDMC), Massachusetts General Hospital (MGH), and the Benson-Henry Institute for Mind Body Medicine at MGH identified genes associated with the body’s response to relaxation techniques and sheds light on the molecular mechanisms by which these interventions may work to lower blood pressure. The findings were published today in the Journal of Alternative and Complementary Medicine.

Released:
3-Apr-2018 4:25 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
ButalaAnnalsvisualabstractv2.png
  • Embargo expired:
    26-Mar-2018 5:00 PM EDT

Article ID: 691616

Study Finds Hospital Quality Report Cards and Readmission Penalties May Not Tell the Whole Story

Beth Israel Deaconess Medical Center

New research finds significant differences in hospitals’ performance when readmissions were assessed for non-Medicare patients and for conditions other than those currently reported, showing that when these additional factors are taken into account, half of hospitals would be subject to a change in their financial penalty status.

Released:
22-Mar-2018 4:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
MantzorosA.jpg

Article ID: 691304

BIDMC’s Christos Mantzoros, MD, MSC, Recognized for Groundbreaking Obesity Research

Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center’s Christos Mantzoros, MD, MSC, the first scientist to document the role of the hormone leptin in regulating the body’s response to hunger in humans, is the recipient of the Endocrine Society’s Outstanding Clinical Investigator Award for 2018. Mantzoros accepted the award today at a special ceremony at the Society’s 100th annual meeting in Chicago.

Released:
16-Mar-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
AMI_spending_final3.png

Article ID: 691139

Study Examines How Hospital Payments for Heart Attack Care May Affect Patient Outcomes

Beth Israel Deaconess Medical Center

A new, large-scale study – led by researchers at the Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center (BIDMC) and published online today in Circulation: Cardiovascular Quality and Outcomes – examined the relationship between 30-day episode spending for inpatient and post-discharge care and patient mortality following a hospital admission for heart attack.

Released:
14-Mar-2018 3:40 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
GabrielBrat20160907_06.jpg

Article ID: 688211

Length of Opioid Prescription, Number of Refills Spell Highest Risk for Misuse After Surgery

Beth Israel Deaconess Medical Center

With opioid overdoses now a leading cause of nonintentional death in the United States, data show most of these deaths can be traced back to an initial prescription opioid. A new study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS) sheds light on the possible link between physicians’ opioid prescription patterns and subsequent abuse.

Released:
19-Jan-2018 2:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment
double-helix.jpg

Article ID: 688073

Non-Coding RNA Precision Diagnostics and Therapeutics Core Facility Opens at Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center

The Cancer Center and the Department of Pathology at Beth Israel Deaconess Medical Center (BIDMC) has opened a new state-of-the-art facility dedicated to the study of non-coding RNAs (ncRNA). The Non-Coding RNA Precision Diagnostics and Therapeutics Core Facility will help accelerate the discovery and translation of ncRNA diagnostics and therapeutics, with the hope of leading to better cures and treatments for disease

Released:
17-Jan-2018 2:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment
PandolfiPressRelease20171116_21a.jpg

Article ID: 687928

Flipping the Switch: Dietary Fat, Changes in Fat Metabolism May Promote Prostate Cancer Metastasis

Beth Israel Deaconess Medical Center

Prostate tumors tend to be what scientists call “indolent” – so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, the disease is invariably fatal. In a set of papers out today in the journals Nature Genetics and Nature Communications, researchers at the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) shed new light on the genetic mechanisms that promote metastasis in the mouse model and also implicated the typical Western high-fat diet as a key environmental factor driving metastasis.

Released:
15-Jan-2018 11:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Comment
prostsate.cancer.jpg

Article ID: 687897

Cancer’s Gene-Determined “Immune Landscape” Dictates Progression of Prostate Tumors

Beth Israel Deaconess Medical Center

The field of immunotherapy – the harnessing of patients’ own immune systems to fend off cancer – is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of patients, suggesting that as-yet unidentified variations among tumors result in distinct paths of disease progression and response to therapy.

Released:
12-Jan-2018 11:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 687021

Can Brain Lesions Contribute to Criminal Behavior?

Beth Israel Deaconess Medical Center

New research published in the Proceedings of the National Academy of Sciences indicates that lesions to brain areas in individuals exhibiting criminal behavior all fall within a particular brain network involved in moral decision-making.

Released:
18-Dec-2017 3:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Showing results

110 of 435





Chat now!